Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Chacko AD, McDade SS, Chanduloy S, Church SW, Kennedy R, Price J, Hall PA, Russell SE.

Cell Oncol (Dordr). 2012 Apr;35(2):85-93. doi: 10.1007/s13402-011-0066-0. Epub 2012 Jan 26.

PMID:
22278362
2.

Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.

Sellin ME, Stenmark S, Gullberg M.

Mol Biol Cell. 2012 Nov;23(21):4242-55. doi: 10.1091/mbc.E12-06-0486. Epub 2012 Sep 5.

3.

Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes.

Froidevaux-Klipfel L, Targa B, Cantaloube I, Ahmed-Zaïd H, Poüs C, Baillet A.

Oncotarget. 2015 Nov 3;6(34):36063-80. doi: 10.18632/oncotarget.5373.

4.

Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.

Connolly D, Hoang HG, Adler E, Tazearslan C, Simmons N, Bernard VV, Castaldi M, Oktay MH, Montagna C.

Biol Chem. 2014 Feb;395(2):157-67. doi: 10.1515/hsz-2013-0247.

PMID:
24127542
5.

Properties of SEPT9 isoforms and the requirement for GTP binding.

Robertson C, Church SW, Nagar HA, Price J, Hall PA, Russell SE.

J Pathol. 2004 May;203(1):519-27.

PMID:
15095474
6.

SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.

Amir S, Mabjeesh NJ.

Cancer Biol Ther. 2007 Dec;6(12):1926-31. Epub 2007 Sep 1.

PMID:
18075300
7.

Translational control of SEPT9 isoforms is perturbed in disease.

McDade SS, Hall PA, Russell SE.

Hum Mol Genet. 2007 Apr 1;16(7):742-52.

PMID:
17468182
8.

Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.

Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P, Montagna C.

Breast Cancer Res. 2011 Aug 10;13(4):R76. doi: 10.1186/bcr2924.

9.

Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.

Estey MP, Di Ciano-Oliveira C, Froese CD, Bejide MT, Trimble WS.

J Cell Biol. 2010 Nov 15;191(4):741-9. doi: 10.1083/jcb.201006031. Epub 2010 Nov 8.

10.

SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission.

Kim MS, Froese CD, Estey MP, Trimble WS.

J Cell Biol. 2011 Nov 28;195(5):815-26. doi: 10.1083/jcb.201106131.

11.

SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.

Peterson EA, Stanbery L, Li C, Kocak H, Makarova O, Petty EM.

Genes Chromosomes Cancer. 2011 Nov;50(11):940-9. doi: 10.1002/gcc.20916. Epub 2011 Aug 24.

12.

Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Peterson EA, Kalikin LM, Steels JD, Estey MP, Trimble WS, Petty EM.

Mamm Genome. 2007 Nov;18(11):796-807. Epub 2007 Oct 6.

PMID:
17922164
13.

High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.

Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM.

Cancer Res. 2007 Sep 15;67(18):8554-64.

14.

Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis.

Scott M, McCluggage WG, Hillan KJ, Hall PA, Russell SE.

Int J Cancer. 2006 Mar 1;118(5):1325-9.

15.

Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.

Ling YH, Jiang JD, Holland JF, Perez-Soler R.

Mol Pharmacol. 2002 Sep;62(3):529-38.

16.

Bcl-xL is phosphorylated in malignant cells following microtubule disruption.

Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T.

Cancer Res. 1998 Aug 1;58(15):3331-8.

17.

DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.

Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN.

Cancer Res. 1999 Aug 1;59(15):3663-70.

18.

βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.

Kanakkanthara A, Northcote PT, Miller JH.

Mol Cancer Ther. 2012 Feb;11(2):393-404. doi: 10.1158/1535-7163.MCT-11-0614. Epub 2011 Dec 16.

19.

Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231.

Froidevaux-Klipfel L, Poirier F, Boursier C, Crépin R, Poüs C, Baudin B, Baillet A.

Proteomics. 2011 Oct;11(19):3877-86. doi: 10.1002/pmic.201000789. Epub 2011 Aug 18.

PMID:
21761557
20.

SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity.

Chacko AD, Hyland PL, McDade SS, Hamilton PW, Russell SH, Hall PA.

J Pathol. 2005 Aug;206(4):458-65.

PMID:
15902694

Supplemental Content

Support Center